Gilead

FILE PHOTO: An ampule of Remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg

Generic Version of Remdesivir to Be Launched in India at Rs 4,800 per 100 mg Vial

Reuters 06/07/2020

Mylan's version comes after two Indian drugmakers, Cipla Ltd...

hal-gatewood-AypaEmWVH8I-unsplash1

COVID-19: Can We Push Pharma Innovation Without Giving Away Pricey Patents?

Chirantan Chatterjee 09/04/2020

Drugs and treatments remain increasingly the only way to...

Gilead Wins Reversal of $2.54 Billion Hepatitis C Drug Patent Verdict

Nate Raymond 21/02/2018

A federal judge in Delaware has overturned a jury's...

People segregate expired medicines outside a chemist store in New Delhi

In India, Stakeholders Drive Down Drug Prices for the Benefit of All

Huizhong Wu, Undark Magazine 10/02/2018

An eclectic mix of activists, generic drug makers, doctors...

medicines-reuters-1

Delhi’s RCEP Talks on Intellectual Property Shouldn’t Forget India’s Role as ‘Pharmacy of the World’

Leena Menghaney 05/02/2018

India must resist pressure and make sure the deal...

gilead

Malaysia Allows Generics for Gilead’s Hepatitis C Drug for Which India Issued Patent

The Wire Staff 19/09/2017

India had first rejected a patent for this breakthrough...

Credit: rico_gustav/Flickr, CC BY 2.0 (patent)

All You Need to Know: September’s Crucial Verdict on the Sofosbuvir Patent Saga

T.V. Padma 03/09/2016

The patent also covers the raw materials to make...